Hypoxemia frequently occurs in critically ill patients as a result of a derangement in the efficiency of pulmonary oxygen uptake from ambient air. Alterations in pulmonary oxygen uptake are caused by ventilation-perfusion (V./Q. ) abnormalities and/or intrapulmonary shunts resulting in reduced arterial oxygen content, which can lead to tissue hypoxia. Consequently, oxygen delivery and the metabolic activity of various organs are altered.
Clinical conditions associated with hypoxemia and changes in oxygen delivery and consumption include acute respiratory distress syndrome (ARDS), sepsis, and trauma. Clinical worsening leads to progressive hypoxemia that may result in tissue hypoxia, which is implicated in the development of multiorgan failure.1 Thus, critically ill patients with sepsis or ARDS are not only in pulmonary peril but are also very likely to be at increased risk for systemic failure.
Regularly evaluating pulmonary oxygen uptake and delivery in critically ill patients provides information about oxygen transport and metabolic activity of peripheral tissue beds, and may allow early detection of tissue hypoxia.
In this article, we will review the dynamics of tissue oxygen balance. We will also describe various techniques for assessing oxygen delivery and will offer suggestions that may help you to better manage critically ill patients.
The terms "acute lung injury" and "ARDS" are used to describe hyp-oxemic respiratory failure in persons who are critically ill. The proposed mechanisms of abnormal oxygen uptake are alveolar edema and atelectasis, conditions that set the stage for shunting and V./Q. mismatching.2 In patients who have ARDS, hypoxemia is caused primarily by right-to-left intrapulmonary shunting of blood, leading to inefficient pulmonary oxygen uptake. Most patients consume a normal amount of oxygen, and tissue hypoxia rarely occurs unless their condition progresses to a terminal stage.
Other conditions that exacerbate oxygen imbalance and are often present in critically ill, mechanically ventilated patients include hypotension, fever, and anemia (see "Understanding oxygen balance"). Reduced blood flow or abnormal microvascular perfusion distribution is a prominent cause of impaired oxygen delivery and uptake. Febrile patients have increased oxygen demands that may further aggravate hypoxemia. In such an environment, the quantity of oxygen available for tissue delivery is diminished. The resulting tissue hypoxia constitutes a condition in which the cells within the tissue bed use more oxygen, which leads to anaerobic metabolism.3
GLOBAL TISSUE OXYGENATION
Initial data using cardiac output and arterial and mixed venous blood oxygen contents suggested that whole body oxygen consumption was dependent on tissue oxygen delivery. This led to the practice of trying to achieve "supranormal" oxygen delivery with the use of vasopressors to increase cardiac output and deliver a greater amount of oxygen to peripheral tissues. This created controversy regarding the best approach to managing oxygen balance in the critically ill patient.
Supranormal delivery describes a strategy in which global oxygen delivery is increased to obtain oxygen delivery, oxygen consumption, and oxygen extraction values that can sustain life. It has been test- ed in clinical trials, with dubious results.
Early studies showed that infusing prostacyclin would increase oxygen delivery without increasing oxygen consumption, improving survival in some critically ill patients.4 This response to prostacyclin was believed to identify patients who had occult tissue hypoxia. The results of this investigation and other nonrandomized studies promulgated the use of vasopressors and inotropes as a means of achieving supranormal oxygen delivery in critically ill patients.5-7
Various investigators noted difficulties in achieving supranormal oxygen delivery.5-7 One problem is the failure to attain target values despite administration of increasing doses of catecholamines. In older or severely ill patients, achieving the target value is difficult. In addition, administration of large doses of dobutamine and norepinephrine to achieve a high cardiac output may lead to tachyarrhythmias, may worsen maldistribution of blood flow, and/or may produce myocardial ischemia.
More recent studies using independent measurements of oxygen consumption and delivery have not revealed a "pathologic" oxygen-supply dependence.8-11 Instead, there is a marked variability in basal whole body oxygen consumption related to the metabolic state of the patient.8-11
Several randomized controlled trials examined the survival benefit of increasing the patient's oxygen delivery to a target cardiac index of more than 4.5 mL/min/m2 and/or mixed venous oxygen saturation (Sv?248-175?O2) of 70% or more. Treatment of patients according to this strategy showed no benefit; to the contrary, mortality was increased.12-16 These studies also showed that using inotropes and vasopressors to increase oxygen to supranormal levels is difficult.14,15
Currently, the use of supranormal oxygen delivery in critically ill patients with existing hypoxia remains largely unjustified by clinical evidence.16 Improvements in global oxygen delivery may be achieved by several means. The first goal is to provide an adequate fraction of inspired oxygen to maintain oxygen saturation at more than 92% or PaO2 at more than 60 mm Hg.
In addition, oxygen-carrying capacity can be improved through the use of packed red blood cell transfusions for volume resuscitation. While the optimal hemoglobin concentration remains unknown, a target value of 10 to 12 g/dL would appear to be appropriate. However, data indicate that lower hemoglobin concentrations (7 to 10 g/dL) may be adequate and that routine transfusions of packed red blood cells to achieve a preselected value are not warranted.17
Alkalemia should be avoided because it impairs dissociation to the tissue. Simultaneously, mechanical ventilatory assistance should be provided using a tidal volume of 6 to 8 mL/kg of ideal body weight, and an attempt should be made to increase end-expiratory lung volume using positive end-expiratory pressure (PEEP) (5 cm H2O). Use of PEEP to increase mean alveolar pressure often succeeds in maintaining an adequate lung volume, thereby improving PaO2.
Low levels of PEEP reduce alveolar atelectasis in dependent portions of the lung and increase PaO2. However, at higher levels of PEEP, cardiac output may decline, leading to decreased oxygen delivery. Thus, optimal PEEP has been defined as the level that optimizes global oxygen delivery.18
PEEP-induced decline in cardiac output may be managed with volume infusion or packed red blood cell transfusion in anemic patients. Other measures involve decreasing oxygen consumption by giving antipyretics for fever and rigors. Minimizing agitation with the use of sedatives may also allow a patient's respiratory pattern to synchronize with the ventilator and avoid excessive muscle activity, thereby diminishing the work and oxygen cost of breathing.
MONITORING GLOBAL OXYGEN DELIVERY
Monitoring the patient for tissue hypoxia may allow early identification and implementation of specific therapies to reverse the process. Tissue hypoxia is assessed on a clinical basis, using biochemical indices, physiologic markers, and specific tissue probes.
Assessment of tissue hypoxia begins with a bedside evaluation. Although the physical findings of hypoxia are nonspecific, the presence of hypotension, tachycardia, tachypnea, mental obtundation, oliguria, cyanosis, pallor, and cool extremities provides strong supportive evidence and suggests organ dysfunction. In patients with sepsis, organ dysfunction may occur even in the absence of systemic hypoperfusion. In this case, systemic blood pressure measurements may not reflect specific organ perfusion and oxygen delivery.
The chief limits of bedside clinical assessment are the nonspecific and unquantifiable nature of these findings, as well as interobserver variability. Nonetheless, serial bedside examinations provide information that can be correlated with specific physiologic and biochemical measurements. One report highlighted the finding that the detection of cool extremities can identify patients with hypoperfusion as noted by elevated lactate levels and a relatively low cardiac output.19
Use of a pulmonary artery catheter allows bedside measurement of hemodynamics and Sv?248-175?O2. Measurements of central venous pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, and cardiac output are routinely obtained. The pulmonary artery catheter is useful in determining intravascular volume status and guiding therapy for shock.
While pulmonary artery catheters are widely used in ICUs, there is concern regarding the lack of improvement in patient outcomes.20,21 An observational study involving more than 5700 critically ill medical and surgical patients raised issues concerning patient safety.22 Various reports have indicated that potential problems with the pulmonary artery catheter may be related to patient selection and data interpretation.23-25 Moreover, a prospective randomized trial reported no benefit to therapy directed by the pulmonary artery catheter compared with standard care of elderly, high-risk surgical patients.26
1. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3 pt 1):818-824.
2. Duarte AG, Bidani A. Monitoring patients with ARDS: pulmonary oxygen uptake. J Crit Illness. 2001;16:38-46.
3. Third European Consensus Conference in Intensive Care Medicine. Tissue hypoxia: how to detect, how to correct, how to prevent. Societe de Reanimation de Langue Francaise, American Thoracic Society, European Society of Intensive Care Medicine. Am J Respir Crit Care Med. 1996;154: 1573-1578.
4. Bihari D, Smithies M, Gimson A, Tinker J. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med. 1987;317:397-403.
5. Vincent JL, Roman A, De Backer D, Kahn RJ. Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion. Am Rev Respir Dis. 1990;142:2-7.
6. Shoemaker WC, Appel PL, Kram HB. Role of oxygen debt in the development of organ failure, sepsis, and death in high-risk surgical patients. Chest. 1992;102:208-215.
7. Astiz ME, Rackow EC, Falk JL, et al. Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med. 1987;15: 26-28.
8. Ronco JJ, Fenwick JC, Tweeddale MG, et al. Identification of critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. JAMA. 1993;270:1724-1730.
9. Ronco JJ, Fenwick JC, Wiggs BR, et al. Oxygen consumption is independent of increases in oxygen delivery by dobutamine in septic patients who have normal or increased plasma lactate. Am Rev Respir Dis. 1993;147:25-31.
10. Manthous CA, Schumacker PT, Pohlman A, et al. Absence of supply dependence of oxygen consumption in patients with septic shock. J Crit Care. 1993;8:203-211.
11. Mira JP, Fabre JE, Baigorri F, et al. Lack of oxygen supply dependency in patients with severe sepsis. A study of oxygen delivery increased by military antishock trouser and dobutamine. Chest. 1994;106:1524-1531.
12. Yu M, Levy MM, Smith P, et al. Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med. 1993; 21:830-838.
13. Bone RC, Slotman G, Maunder R, et al. Randomized double-blind, multicenter study of prostaglandin E1 in patients with adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest. 1989;96:114-119.
14. Hayes MA, Timmins AC, Yau EH, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med. 1994;330: 1717-1722.
15. Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333:1025-1032.
16. Russell JA, Phang PT. The oxygen delivery/consumption controversy. Approaches to management of the critically ill. Am J Respir Crit Care Med. 1994;149:533-537.
17. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group [published correction appears in N Engl J Med. 1999;340:1056]. N Engl J Med. 1999;340:409-417.
18. Suter PM, Fairley B, Isenberg MD. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med. 1975;292: 284-289.
19. Kaplan LJ, McPartland K, Santora TA, Trooskin SZ. Start with a subjective assessment of skin temperature to identify hypoperfusion in intensive care unit patients. J Trauma. 2001;50:620-628.
20. Zion MM, Balkin J, Rosenmann D, et al. Use of pulmonary artery catheters in patients with acute myocardial infarction. Analysis of experience in 5841 patients in SPRINT registry. SPRINT Study Group. Chest. 1990;98:1331-1335.
21. Gore JM, Goldberg RJ, Spodick DH, et al. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest. 1987;92:721-727.
22. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA. 1996;276:889-897.
23. Bernard GR, Sopko G, Cerra F, et al. Pulmonary artery catheterization and clinical outcomes: National Heart, Lung, and Blood Institute and Food and Drug Administration Workshop Report. JAMA. 2000;283:2568-2572.
24. Gnaegi A, Feihl F, Perret C. Intensive care physicians' insufficient knowledge of right-heart catheterization at the bedside: time to act? Crit Care Med. 1997;25:213-220.
25. Hoyt JD, Leatherman JW. Interpretation of the pulmonary artery occlusion pressure in mechanically ventilated patients with large respiratory excursions in intrathoracic pressure. Intensive Care Med. 1997;23:1125-1131.
26. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5-14.
27. Fahey PJ, Harris K, Vanderwarf C. Clinical experience with continuous monitoring of mixed venous saturation in respiratory failure. Chest. 1984; 86:748-752.
28. Lee J, Wright F, Barber R, Stanley L. Central venous oxygen saturation in shock: a study in man. Anesthesiology. 1972;36:472-478.
29. Edwards JD, Mayall RM. Importance of the sampling site for measurement of mixed venous oxygen saturation in shock. Crit Care Med. 1998; 26:1356-1360.
30. Fahey PJ. Clinical and physiologic rationale for continuous measurement of mixed venous oxygen saturation. In: Tobin MJ, ed. Contemporary Management in Critical Care. New York: Churchill Livingstone; 1995:101-118.
31. Krafft P, Steltzer H, Hiesmayr M, et al. Mixed venous oxygen saturation in critically ill septic shock patients. The role of defined events. Chest. 1993;103:900-906.
32. Cariou A, Monchi M, Dhainaut JF. Continuous cardiac output and mixed venous oxygen saturation monitoring. J Crit Care. 1998;13:198-213.
33. Vincent JL. The available clinical tools--oxygen derived variables, lactate, and pHi. In: Sibbald WJ, Messmer K, Fink MP, eds. Tissue Oxygenation in Acute Medicine. New York: Springer-Verlag; 1998:193-203.
34. Gutierrez G, Clark C, Brown SD, et al. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med. 1994;150:324-329.
35. Hotchkiss RS, Rust RS, Dence CS, et al. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. Am J Physiol. 1991;261:R965-R972.
36. Gore DC, Jahoor F, Hibbert JM, DeMaria EJ. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg. 1996;224:97-102.
37. Bakker J, Gris P, Coffernils M, et al. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996;171:221-226.
38. Roumen RM, Redl H, Schlag G, et al. Scoring systems and blood lactate concentrations in relation to the development of adult respiratory distress syndrome and multiple organ failure in severely traumatized patients. J Trauma. 1993; 35:349-355.
39. Bakker J, Coffernils M, Leon M, et al. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest. 1991;99:956-962.
40. Friedman G, Berlot G, Kahn RJ, Vincent JL. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med. 1995; 23:1184-1193.
41. Bernardin G, Pradier C, Tiger F, et al. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med. 1996;22:17-25.
42. Jakob SM, Takala J. ARDS. Monitoring tissue perfusion. Crit Care Clin. 2002;18:143-163.
43. Brown SD, Gutierrez G. Gut mucosal pH monitoring. In: Tobin MJ, ed. Principles and Practice of Intensive Care Monitoring. New York: McGraw Hill Co; 1998:351-368.
44. Gutierrez G, Palizas F, Doglio G, et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients. Lancet. 1992; 339:195-199.
45. Carrico CJ, Meakins JL, Marshall JC, et al. Multiple-organ-failure syndrome. Arch Surg. 1986;121:196-208.
46. Dantzker DR. The gastrointestinal tract. The canary of the body? JAMA. 1993;270:1247-1248.
47. Manthous CA, Hall JB, Olson D, et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med. 1995;151:10-14.
48. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999;27:200-210.
49. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345:1368-1377.
50. Hebert PC, Yetisir E, Martin C, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med. 2001;29:227-234.
51. Practice parameters for hemodynamic support in adult patients with sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 1999;27:639-660.
52. Nunn JF. Oxygen. In: Nunn JF, ed. Nunn's Applied Respiratory Physiology. Oxford, UK: Butterworth-Heinemann; 1993:247-305.
53. Phang P, Cunningham K, Ronco J, et al. Mathematical coupling explains dependence of oxygen consumption on oxygen delivery in ARDS. Am J Respir Crit Care Med. 1994;150: 318-323.